The D-K6L9 peptide induced a two-step cytolytic effect via membrane disruption and necrosis of tumor cells alongside with a decrease in the tumor vessel density, formation of new capillary tubes and in the secretion of prostate-specific antigen secretion. The gene discussed is KLK3; the disease is neoplasm.